Scopolamine (CED0001890)

Record Information
Version1.0
Creation Date2009-07-21 20:27:33 UTC
Update Date2026-05-14 16:47:46 UTC
Accession NumberCHEM002264
Identification
Common NameScopolamine
ClassSmall Molecule
Description
Scopolamine is an exogenous solid compound with the formula C17H21NO4 and an average molecular weight of 303.35 g/mol. Scopolamine belongs to the beta hydroxy acids and derivatives, a subclass of hydroxy acids and derivatives within the organic compounds. It functions as a metabolite and a muscarinic antagonist, interfering with the transmission of nerve impulses by acetylcholine in the parasympathetic nervous system, specifically the vomiting center. Its recorded protein targets include the Muscarinic acetylcholine receptor M1 (CHRM1), which it inhibits, the Muscarinic acetylcholine receptor M2 (CHRM2), Muscarinic acetylcholine receptor M3 (CHRM3), Muscarinic acetylcholine receptor M4 (CHRM4), and the intestinal sucrase-isomaltase (SI), which it induces, among three other proteins. The compound is used as an antiemetic, antispasmodic drug, mydriatic agent, antidepressant, adjuvant, and anaesthesia adjuvant. It has been detected in the brain, nerve cells, neuron, adipose tissue, and stratum corneum. Exposure routes include oral, buccal, sublingual, inhalation, intravenous, intramuscular, subcutaneous, transdermal, transmucosal, topical, touch, and ophthalmic administration. Scopolamine is found in 40 recorded sources across various sectors. These include healthcare, pharmaceuticals and veterinary products (such as hypnotics and sedatives, mydriatics and cycloplegics, antiemetics and antinauseants, and medical devices); food, food processing and cookware (including food preservation, food packaging, and the preparation of vinegar, wine, or sparkling wine, as well as fermentation processes for beer); household cleaning and consumer products (including perfumes within detergents and soaps, cigar cigarettes, pipe accessories, and non-electric simulated smoking devices); electrical and electronic equipment (such as batteries, capacitors, cell phones, printed circuit boards, and wires and cables); textiles, leather and furnishings (including synthetic textiles, carpets and rugs); and drinking water and water supply.
Contaminant Type
  • Adjuvant
  • Adjuvant, Anesthesia
  • Amine
  • Antimuscarinic
  • Antispasmodic
  • Cholinergic Antagonist
  • Drug
  • Ester
  • Ether
  • Food Toxin
  • Metabolite
  • Muscarinic Antagonist
  • Mydriatic
  • Natural Compound
  • Organic Compound
  • PFAS
  • Phytotoxin
  • Plant Toxin
Chemical Structure
Synonyms
ValueSource
(-)-HyoscineChEBI
(-)-ScopolamineChEBI
(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoateChEBI
6,7-Epoxytropine tropateChEBI
6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropateChEBI
alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl esterChEBI
HyoscineChEBI
Scopine (-)-tropateChEBI
Transderm-scopChEBI
(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoic acidGenerator
6,7-Epoxytropine tropic acidGenerator
6-b,7-b-Epoxy-3-a-tropanyl S-(-)-tropateGenerator
6-b,7-b-Epoxy-3-a-tropanyl S-(-)-tropic acidGenerator
6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropic acidGenerator
6-Β,7-β-epoxy-3-α-tropanyl S-(-)-tropateGenerator
6-Β,7-β-epoxy-3-α-tropanyl S-(-)-tropic acidGenerator
a-(Hydroxymethyl)benzeneacetate 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl esterGenerator
a-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl esterGenerator
alpha-(Hydroxymethyl)benzeneacetate 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl esterGenerator
Α-(hydroxymethyl)benzeneacetate 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl esterGenerator
Α-(hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl esterGenerator
Scopine (-)-tropic acidGenerator
(+)-HyoscineHMDB
(+)-ScopolamineHMDB
(-)-Hyoscine hydrobromideHMDB
(-)-Scopolamine bromideHMDB
(-)-Scopolamine hydrobromideHMDB
AtrochinHMDB
AtroquinHMDB
BeldavrinHMDB
BuscopanHMDB
Epoxytropine tropateHMDB
EuscopolHMDB
Hydroscine hydrobromideHMDB
HyosceineHMDB
Hyoscine bromideHMDB
Hyoscine hydrobromideHMDB
Hyoscyine hydrobromideHMDB
HyosolHMDB
HyscoHMDB
Isopto hyoscineHMDB
IsoscopilHMDB
KwellsHMDB
L-Hyoscine hydrobromideHMDB
L-Scopolamine-hydrobromideHMDB
Methscopolamine bromideHMDB
OscineHMDB
PamineHMDB
S-(-)-TropateHMDB
ScopHMDB
ScopaminHMDB
Scopine tropateHMDB
Scopolamine bromideHMDB
Scopolamine hydrobromideHMDB
Scopolaminium bromideHMDB
Scopolammonium bromideHMDB
SEEHMDB
TranaxineHMDB
NorhyoscineHMDB
6beta,7beta-Epoxy-3alpha-tropanyl S-(-)-tropatePhytoBank
6β,7β-Epoxy-3α-tropanyl S-(-)-tropatePhytoBank
9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol (-)-tropatePhytoBank
l-ScopolaminePhytoBank
(-)-AtropinePhytoBank
(-)-HyoscyaminePhytoBank
(S)-(-)-HyoscyaminePhytoBank
(S)-AtropinePhytoBank
1alphaH,5alphaH-Tropan-3alpha-yl (-)-tropatePhytoBank
1αH,5αH-Tropan-3α-yl (-)-tropatePhytoBank
CystospazPhytoBank
DaturinePhytoBank
DuboisinePhytoBank
HyoscyaminePhytoBank
L-HyoscyaminPhytoBank
l-HyoscyaminePhytoBank
l-AtropinePhytoBank
l-Tropine tropatePhytoBank
(±)-AtropinePhytoBank
(±)-HyoscyaminePhytoBank
AtropinPhytoBank
AtropinePhytoBank
Atropinum sulfuricumPhytoBank
Atropinum sulphuricumPhytoBank
dl-HyoscyaminePhytoBank
Tropine (±)-tropatePhytoBank
Tropine tropatePhytoBank
dl-Tropyl tropatePhytoBank
Chemical FormulaC17H21NO4
Average Molecular Mass303.353 g/mol
Monoisotopic Mass303.147 g/mol
CAS Registry Number51-34-3
IUPAC Name(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate
Traditional Name(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate
SMILESCN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
InChI IdentifierInChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11-,12-,13-,14+,15-,16+/m1/s1
InChI KeySTECJAGHUSJQJN-FWXGHANASA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassHydroxy acids and derivatives
Sub ClassBeta hydroxy acids and derivatives
Direct ParentBeta hydroxy acids and derivatives
Alternative Parents
Substituents
  • Beta-hydroxy acid
  • Monocyclic benzene moiety
  • Morpholine
  • Oxazinane
  • Piperidine
  • N-alkylpyrrolidine
  • Benzenoid
  • Pyrrolidine
  • Amino acid or derivatives
  • Carboxylic acid ester
  • Tertiary amine
  • Tertiary aliphatic amine
  • Oxacycle
  • Organoheterocyclic compound
  • Azacycle
  • Carboxylic acid derivative
  • Dialkyl ether
  • Oxirane
  • Ether
  • Monocarboxylic acid or derivatives
  • Primary alcohol
  • Organopnictogen compound
  • Organonitrogen compound
  • Organooxygen compound
  • Amine
  • Organic oxide
  • Carbonyl group
  • Organic oxygen compound
  • Organic nitrogen compound
  • Alcohol
  • Hydrocarbon derivative
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Cytoplasm
  • Extracellular
  • Membrane
Biofluid LocationsNot Available
Tissue Locations
  • Adipose Tissue
  • Brain
  • Nerve Cells
  • Neuron
  • Stratum Corneum
Applications
Biological Roles
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateSolid
AppearanceWhite powder.
Experimental Properties
PropertyValue
Melting Point59°C
Boiling PointNot Available
Solubility1E+005 mg/L
Predicted Properties
PropertyValueSource
Water Solubility6.61 g/LALOGPS
logP1.4ALOGPS
logP0.89ChemAxon
logS-1.7ALOGPS
pKa (Strongest Acidic)15.15ChemAxon
pKa (Strongest Basic)6.95ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area62.3 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity79.72 m³·mol⁻¹ChemAxon
Polarizability31.24 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
GC-MSGC-MS Spectrumsplash10-0f7c-7900000000-28f924e821203772c1adNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-00di-4910000000-24c90e50ab88ad57e82cNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-0006-4900000000-596180a39c76ec0fe1aeNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0udi-0009000000-9733effdc3262b114ed6Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0udi-0809000000-a686e4c768aedb57cf8eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-1901000000-f66f538c7db471e86fd5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-3900000000-5eedeba4bedea55de9adNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0udr-7900000000-1309364bbca3810a6afaNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-1c1d2f52fb7a5d745e1eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0udi-9700000000-80887cb9e3f0d05c8bf5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0udi-9800000000-80887cb9e3f0d05c8bf5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0udi-6900000000-010e6e0ca9f0d9f3618bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0f79-4900000000-a0695c5add6db92de8b2Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-2900000000-887570e409db5eca481cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0f79-4900000000-5e1feadfe643a530d956Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-2900000000-9556767e32b410cf8d73Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0udi-0309000000-fda2d2422fa0a3b4172eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0k9i-0903000000-cc938997b1c67e020c14Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0f79-0955000000-64498c50c4e2afb15c32Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-1930000000-5d768d7bc9f10614fd97Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0lxt-4900000000-f39cfd7374383b7b1aafNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0udi-0549000000-2102ba2525a572e05e74Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0uk9-1952000000-23caf7102d633b0031b2Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0hr0-4900000000-854ad2f78678cc2d4db3Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0f6t-0904000000-0366209ad3f767f88736Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0f79-1900000000-bd791764fd2502fdc39dNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0gb9-2910000000-c7c4ffc22c1425ab3dbdNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0udi-0019000000-cc4ab81a673ee149c93eNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0udi-0429000000-48f2a2d6a6bb3fbcd837Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0006-6910000000-719e539fec930d736ea5Not AvailableView Spectrum
1D NMR1H NMR Spectrum (1D, D2O, predicted)Not AvailableNot AvailableView Spectrum
1D NMR13C NMR Spectrum (1D, D2O, predicted)Not AvailableNot AvailableView Spectrum
Toxicity Profile
Mechanism of ToxicityScopolamine acts by interfering with the transmission of nerve impulses by acetylcholine in the parasympathetic nervous system (specifically the vomiting center).
Carcinogenicity (IARC Classification)No indication of carcinogenicity to humans (not listed by IARC).
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
1284.0Log mg/kg[720:2300]RatLD50oralpredictedNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
7PesticidesAgriculture & land managementNot Available
10InsecticidesAgriculture & land managementNot Available
115Drinking waterDrinking water & water supplyNot Available
120Wires and cablesElectrical & Electronic EquipmentNot Available
121Printed circuit boardsElectrical & Electronic EquipmentNot Available
125BatteriesElectrical & Electronic EquipmentNot Available
130SemiconductorsElectrical & Electronic EquipmentNot Available
138LubricantsEnergy, oil & gasNot Available
147Food packagingFood, food processing & cookwareNot Available
174LubricantsIndustrial manufacturing & chemical processingNot Available
234Medical devicesHealthcare, pharmaceuticals & veterinary productsNot Available
249Antiemetics and antinauseantsHealthcare, pharmaceuticals & veterinary productsNot Available
376Hypnotics and sedativesHealthcare, pharmaceuticals & veterinary productsNot Available
399Mydriatics and cycloplegicsHealthcare, pharmaceuticals & veterinary productsNot Available
451Carpets and RugsTextiles, leather & furnishingsNot Available
454Synthetic textilesTextiles, leather & furnishingsNot Available
490Personal care & cosmeticsNot Available
492Cell phonesElectrical & Electronic EquipmentNot Available
493CapacitorsElectrical & Electronic EquipmentNot Available
500Stairs And RampsBuilding & ConstructionNot Available
505AmplifiersElectrical & Electronic EquipmentNot Available
506AntennasElectrical & Electronic EquipmentNot Available
511Conductors Or Conductive Bodies Characterised By The Conductive MaterialsElectrical & Electronic EquipmentNot Available
516Electric Hearing AidsElectrical & Electronic EquipmentNot Available
518Electrically Stimulated Smoking DevicesElectrical & Electronic EquipmentNot Available
519ElectrodesElectrical & Electronic EquipmentNot Available
524Hybrid CapacitorsElectrical & Electronic EquipmentNot Available
527MagnetsElectrical & Electronic EquipmentNot Available
537Television SystemsElectrical & Electronic EquipmentNot Available
539Video GamesElectrical & Electronic EquipmentNot Available
544Fermentation Processes For BeerFood, food processing & cookwareNot Available
545Food PreservationFood, food processing & cookwareNot Available
548Preparation Of VinegarFood, food processing & cookwareNot Available
549Preparation Of Wine Or Sparkling WineFood, food processing & cookwareNot Available
556Cigar CigarettesHousehold cleaning & consumer productsNot Available
559Non Electric Simulated Smoking DevicesHousehold cleaning & consumer productsNot Available
560Other Smoking RequisitesHousehold cleaning & consumer productsNot Available
561Perfumes Within Detergents And SoapsHousehold cleaning & consumer productsNot Available
562Pipe AccessoriesHousehold cleaning & consumer productsNot Available
563Soap DetergentsHousehold cleaning & consumer productsNot Available
564Soap DispensersHousehold cleaning & consumer productsNot Available
569Tobacco Smoke FiltersHousehold cleaning & consumer productsNot Available
578Making CigarsIndustrial manufacturing & chemical processingNot Available
580Manufacture Preparation Of Tobacco ProductsIndustrial manufacturing & chemical processingNot Available
596AcaricidesAgriculture & land managementNot Available
600Herbicides And AlgicidesAgriculture & land managementNot Available
602MolluscicidesAgriculture & land managementNot Available
603NematocidesAgriculture & land managementNot Available
605Pest RepellantsAgriculture & land managementNot Available
606Plant Growth RegulatorsAgriculture & land managementNot Available
607Rodenticides(1)Agriculture & land managementNot Available
608RodenticidesAgriculture & land managementNot Available
609AftershavePersonal care & cosmeticsNot Available
610Aftersun ProductsPersonal care & cosmeticsNot Available
611Anti Perspirants Or Body DeoderantsPersonal care & cosmeticsNot Available
612Body Washing Or Cleaning ImplementsPersonal care & cosmeticsNot Available
613DepilatoriesPersonal care & cosmeticsNot Available
614Essential Oils Or PerfumesPersonal care & cosmeticsNot Available
615Eye Makeup ProductsPersonal care & cosmeticsNot Available
616Face Mask CosmeticsPersonal care & cosmeticsNot Available
617Lip Care ProductsPersonal care & cosmeticsNot Available
618Lip Makeup ProductsPersonal care & cosmeticsNot Available
632ApparelTextiles, leather & furnishingsNot Available
642FootwearTextiles, leather & furnishingsNot Available
643HeadwearTextiles, leather & furnishingsNot Available
650Purses Luggage Hand BagsTextiles, leather & furnishingsNot Available
662Yarns Or ThreadsTextiles, leather & furnishingsNot Available
663Sanitary EquipmentWastewater, sanitation & biosolidsNot Available
Pathways
2 pathways
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Muscarinic acetylcholine receptor M1 structureClick to view 3D structureMuscarinic acetylcholine receptor M1P11229HumansPredicted (SEA)0.622794
Muscarinic acetylcholine receptor M5 structureClick to view 3D structureMuscarinic acetylcholine receptor M5P08912HumansPredicted (SEA)0.155698
Muscarinic acetylcholine receptor M2 structureClick to view 3D structureMuscarinic acetylcholine receptor M2P08172HumansPredicted (SEA)0.233548
Muscarinic acetylcholine receptor M3 structureClick to view 3D structureMuscarinic acetylcholine receptor M3P20309HumansPredicted (SEA)0.311397
Click to view 3D structureMuscarinic acetylcholine receptor M3P08483Rattus norvegicusPredicted (SEA)0.0778492
Click to view 3D structureMuscarinic receptor 4Q8VH25Cavia porcellusPredicted (SEA)0.155698
Muscarinic acetylcholine receptor M4 structureClick to view 3D structureMuscarinic acetylcholine receptor M4P08173HumansPredicted (SEA)0.700643
Click to view 3D structureMuscarinic acetylcholine receptor M1P08482Rattus norvegicusPredicted (SEA)0.778492
Click to view 3D structureMuscarinic acetylcholine receptor M2P10980Rattus norvegicusPredicted (SEA)1.32344
Click to view 3D structureMuscarinic acetylcholine receptor M3Q8VH26Cavia porcellusPredicted (SEA)1.32344
Click to view 3D structureMuscarinic acetylcholine receptor M1Q8WMX0Bos taurusPredicted (SEA)0.467095
Click to view 3D structureMuscarinic acetylcholine receptor M4P08485Rattus norvegicusPredicted (SEA)1.08989
Click to view 3D structureMuscarinic acetylcholine receptor M5P08911Rattus norvegicusPredicted (SEA)1.01204
Click to view 3D structureMuscarinic acetylcholine receptor DM1P16395Drosophila melanogasterPredicted (SEA)0.233548
Click to view 3D structureMuscarinic receptor 2Q8VH27Cavia porcellusPredicted (SEA)1.01204
5-hydroxytryptamine receptor 2C structureClick to view 3D structure5-hydroxytryptamine receptor 2CP28335HumansPredicted (SEA)170.801
Click to view 3D structureAlpha-1D adrenergic receptorP25100HumansPredicted (SEA)60.6445
Click to view 3D structureSodium-dependent dopamine transporterP23977Rattus norvegicusPredicted (SEA)94.6646
Click to view 3D structureAcetylcholine-binding proteinP58154Lymnaea stagnalisPredicted (SEA)5.52729
Click to view 3D structureGlutathione S-transferase theta-1Q01579Rattus norvegicusPredicted (SEA)1.63483
Click to view 3D structureSodium-dependent serotonin transporterP31652Rattus norvegicusPredicted (SEA)220.235
Click to view 3D structureNorepinephrine transporterQ9WTR4Rattus norvegicusPredicted (SEA)85.8677
Click to view 3D structureAcetylcholinesteraseP21836Mus musculusPredicted (SEA)75.1245
Sodium-dependent dopamine transporter structureClick to view 3D structureSodium-dependent dopamine transporterQ01959HumansPredicted (SEA)351.801
Sodium-dependent noradrenaline transporter structureClick to view 3D structureSodium-dependent noradrenaline transporterP23975HumansPredicted (SEA)360.675
Muscarinic acetylcholine receptor M2 structureClick to view 3D structureMuscarinic acetylcholine receptor M2P08172HumansKnownNot Available
Muscarinic acetylcholine receptor M1 structureClick to view 3D structureMuscarinic acetylcholine receptor M1P11229HumansKnownScopolamine acts by interfering with the transmission of nerve impulses by acetylcholine in the parasympathetic nervous system (specifically the vomiting center).
Muscarinic acetylcholine receptor M3 structureClick to view 3D structureMuscarinic acetylcholine receptor M3P20309HumansKnownNot Available
Muscarinic acetylcholine receptor M4 structureClick to view 3D structureMuscarinic acetylcholine receptor M4P08173HumansKnownNot Available
Muscarinic acetylcholine receptor M5 structureClick to view 3D structureMuscarinic acetylcholine receptor M5P08912HumansKnownNot Available
Sucrase-isomaltase, intestinal structureClick to view 3D structureSucrase-isomaltase, intestinalP14410HumansKnownNot Available
Concentrations
Not Available
External Links
DrugBank IDDB00747
HMDB IDHMDB0003573
FooDB IDFDB023199
Phenol Explorer IDNot Available
KNApSAcK IDC00002292
BiGG IDNot Available
BioCyc IDSCOPOLAMINE
METLIN ID3433
PDB IDNot Available
Wikipedia LinkScopolamine
Chemspider ID10194106
ChEBI ID16794
PubChem Compound IDNot Available
Kegg Compound IDC01851
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis Reference

Yang Guodong, “Preparation and application of scopolamine and chlorpromazine as a drug-withdrawal agent.” U.S. Patent US5543407, issued February, 1993.

MSDSLink
General References
1. https://www.ncbi.nlm.nih.gov/pubmed/?term=11718188
2. https://www.ncbi.nlm.nih.gov/pubmed/?term=23334071
3. Chemnitius, F. Method for the technical preparation of scopolamine. Journal fuer Praktische Chemie (Leipzig) (1928), 120 221-4.
4. Lee HW, Park WS, Kim YW, Cho SH, Kim SS, Seo JH, Lee KT: A rapid and sensitive liquid chromatography/positive ion tandem mass spectrometry method for the determination of cimetropium in human plasma by liquid-liquid extraction. J Mass Spectrom. 2006 Jul;41(7):855-60.
5. Blin J, Piercey MF, Giuffra ME, Mouradian MM, Chase TN: Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography. J Neurol Sci. 1994 May;123(1-2):44-51.
6. Frey KA, Koeppe RA, Mulholland GK, Jewett D, Hichwa R, Ehrenkaufer RL, Carey JE, Wieland DM, Kuhl DE, Agranoff BW: In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography. J Cereb Blood Flow Metab. 1992 Jan;12(1):147-54.
7. Kranke P, Morin AM, Roewer N, Wulf H, Eberhart LH: The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg. 2002 Jul;95(1):133-43, table of contents.
8. Hagemann K, Piek K, Stockigt J, Weiler EW: Monoclonal antibody-based enzyme immunoassay for the quantitative determination of the tropane alkaloid, scopolamine. Planta Med. 1992 Feb;58(1):68-72.
9. Boumba VA, Mitselou A, Vougiouklakis T: Fatal poisoning from ingestion of Datura stramonium seeds. Vet Hum Toxicol. 2004 Apr;46(2):81-2.
10. Rosier A, Cornette L, Orban GA: Scopolamine-induced impairment of delayed recognition of abstract visual shapes. Neuropsychobiology. 1998;37(2):98-103.
11. Smith AM, Cadoret G, St-Amour D: Scopolamine increases prehensile force during object manipulation by reducing palmar sweating and decreasing skin friction. Exp Brain Res. 1997 May;114(3):578-83.
12. Ebert U, Grossmann M, Oertel R, Gramatte T, Kirch W: Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers. J Clin Pharmacol. 2001 Jan;41(1):51-60.
13. Renner UD, Oertel R, Kirch W: Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit. 2005 Oct;27(5):655-65.
14. Gordon C, Ben-Aryeh H, Attias J, Szargel R, Gutman D: Effect of transdermal scopolamine on salivation. J Clin Pharmacol. 1985 Sep;25(6):407-12.
15. Fan Y, Hu J, Li J, Yang Z, Xin X, Wang J, Ding J, Geng M: Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neurosci Lett. 2005 Feb 21;374(3):222-6. Epub 2004 Dec 10.
16. Stetina PM, Madai B, Kulemann V, Kirch W, Joukhadar C: Pharmacokinetics of scopolamine in serum and subcutaneous adipose tissue in healthy volunteers. Int J Clin Pharmacol Ther. 2005 Mar;43(3):134-9.
17. Schwarz RD, Callahan MJ, Coughenour LL, Dickerson MR, Kinsora JJ, Lipinski WJ, Raby CA, Spencer CJ, Tecle H: Milameline (CI-979/RU35926): a muscarinic receptor agonist with cognition-activating properties: biochemical and in vivo characterization. J Pharmacol Exp Ther. 1999 Nov;291(2):812-22.
18. Suojaranta-Ylinen R, Hendolin H, Tuomisto L: The effects of morphine, morphine plus scopolamine, midazolam and promethazine on cerebrospinal fluid histamine concentration and postoperative analgesic consumption. Agents Actions. 1991 May;33(1-2):212-4.
19. Dreyfuss P, Vogel D, Walsh N: The use of transdermal scopolamine to control drooling. A case report. Am J Phys Med Rehabil. 1991 Aug;70(4):220-2.
20. Putcha L, Cintron NM, Tsui J, Vanderploeg JM, Kramer WG: Pharmacokinetics and oral bioavailability of scopolamine in normal subjects. Pharm Res. 1989 Jun;6(6):481-5.